Skip to main content

MoneyWorks4Me

Gland Pharma informs about analyst meet intimation

24 Nov 2022 Evaluate
Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed about the schedule of Analyst/ Institutional Investor Meeting with the Company on 24th November 2022. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..